Evidence map›Paper›PMID 35254097›Full record

ArticleApplied and environmental microbiology2022

Tanya Laird, Rebecca Abraham, Shafi Sahibzada, Sam Abraham, Mark O'Dea

Open access · greenAbstract read
In one paragraph

Article in Applied and environmental microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. A newFrontiers in microbiology · 2024
    Article
  3. Decolonizing drug-resistantMicrobiology (Reading, England) · 2023
    Article
  4. Development of an In Vivo Extended-Spectrum Cephalosporin-ResistantAnimals : an open access journal from MDPI · 2023
    Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Tanya LairdAntimicrobial Resistance and Infectious Disease Laboratory, Harry Butler Institute, Murdoch Universitygrid.1025.6, Murdoch, Western Australia, Australia.
Rebecca AbrahamAntimicrobial Resistance and Infectious Disease Laboratory, Harry Butler Institute, Murdoch Universitygrid.1025.6, Murdoch, Western Australia, Australia.
Shafi SahibzadaAntimicrobial Resistance and Infectious Disease Laboratory, Harry Butler Institute, Murdoch Universitygrid.1025.6, Murdoch, Western Australia, Australia.ORCID 0000-0001-7362-8323
Sam Abraham *Antimicrobial Resistance and Infectious Disease Laboratory, Harry Butler Institute, Murdoch Universitygrid.1025.6, Murdoch, Western Australia, Australia.ORCID 0000-0003-0950-2317
Mark O'Dea *Antimicrobial Resistance and Infectious Disease Laboratory, Harry Butler Institute, Murdoch Universitygrid.1025.6, Murdoch, Western Australia, Australia.
Murdoch University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extended-spectrum cephalosporin-resistant (ESC-R) Escherichia coli have disseminated in food-producing animals globally, attributed to horizontal transmission of

Indexed as

BacteriophagesEscherichia coli InfectionsPhage TherapyAnimalsAnti-Bacterial Agentsbeta-LactamasesCephalosporinsEscherichia coliAnti-Bacterial Agentsbeta-LactamasesCephalosporinsantimicrobial resistancebacteriophage geneticsbacteriophage therapy

Identifiers

PMID35254097
PMCPMC9004402
OpenAlexW4220750497

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.